Filed: 4/2/2026ACC: 0000024741-26-000163
Officer· Senior VP & GM, Life Sciences
Since Oct 2020
+4.06K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.06K acquired
Non-Derivative Transactions0
No non-derivative transactions reported
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
4.06K shares
Shares
+4.06K
Strike price
Held after
4.06K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock4.06K shares | 4/1/2026 | A · Award | +4.06K | — | 4.06K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned34.08K
Total
34.08K direct34.08K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 34.08K | Direct |
| Total | 34.08K | 34.08K direct |
Derivative Holdings (Post-Transaction)3
Restricted Stock Unit
DirectUnderlying security
Common Stock
Underlying shares
14.33K
Shares owned
14.33K
Exercise price
Expiration
—
Exercise window
—
Restricted Stock Unit
DirectUnderlying security
Common Stock
Underlying shares
11.61K
Shares owned
11.61K
Exercise price
Expiration
—
Exercise window
—
Restricted Stock Unit
DirectUnderlying security
Common Stock
Underlying shares
15.33K
Shares owned
15.33K
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
41.28K
Owned
41.28K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock | — | — | 14.33K | 14.33K | |
| Restricted Stock Unit Direct | Common Stock | — | — | 11.61K | 11.61K | |
| Restricted Stock Unit Direct | Common Stock | — | — | 15.33K | 15.33K | |
| Total | 41.28K | 41.28K | ||||